Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Inflammation of the iris and anterior chamber of the eye.
Biomarker and diagnostic research for anterior uveitis has been reported in the published literature.
1 FDA-approved treatment is available for anterior uveitis, including DIFLUPREDNATE OPHTHALMIC (DIFLUPREDNATE OPHTHALMIC, approved 2008).
Brand Name | Generic Name | Mechanism | Approved | Market Status |
|---|---|---|---|---|
Estimated prevalence: Unknown (Unknown prevalence).
9 clinical trials registered, 2 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 2 PHASE3, 2 PHASE2. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06431373](https://clinicaltrials.gov/study/NCT06431373) |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
DIFLUPREDNATE OPHTHALMIC
DIFLUPREDNATE OPHTHALMIC |
— |
2008 |
Available |
Gene therapy approaches for anterior uveitis have been reported in the published literature.
9 trials found
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
PHASE3 |
Priovant Therapeutics, Inc. |
ACTIVE_NOT_RECRUITING |
[NCT01277419](https://clinicaltrials.gov/study/NCT01277419) | German Spondyloarthritis Inception Cohort | — | Charite University, Berlin, Germany | UNKNOWN |
[NCT07285070](https://clinicaltrials.gov/study/NCT07285070) | Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis | PHASE2 | Novaliq GmbH | RECRUITING |
[NCT07136805](https://clinicaltrials.gov/study/NCT07136805) | A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis | PHASE3 | VivaVision Biotech, Inc | ACTIVE_NOT_RECRUITING |
[NCT05960864](https://clinicaltrials.gov/study/NCT05960864) | Chinese Spondyloarthritis Inception Cohort (CESPIC) | — | Southwest Hospital, China | UNKNOWN |
315 publications have been identified in PubMed for anterior uveitis. Kisho has analyzed 122 by research type. Research spans Review / Meta-Analysis (23%), Epidemiology / Natural History (20%), and Case Report / Case Series (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 28 | 23% |
Disease patterns and progression | 25 | 20% |
Patient case studies | 22 | 18% |
Clinical study results | 20 | 16% |
Laboratory research | 13 | 11% |
Testing and diagnosis research | 10 | 8% |
New treatment approaches | 3 | 2% |
Other research | 1 | 1% |
T Mohd Yatim TAIB (2026). [PMID: 42017386](https://pubmed.ncbi.nlm.nih.gov/42017386/). *Reumatismo*. [Basic Science / Preclinical]
Kaur K (2026). [PMID: 35201717](https://pubmed.ncbi.nlm.nih.gov/35201717/). *Unknown Journal*. [Epidemiology / Natural History]
Li G (2026). [PMID: 41996359](https://pubmed.ncbi.nlm.nih.gov/41996359/). *Ocul Immunol Inflamm*. [Clinical Trial Publication]
Parameswaran P (2026). [PMID: 31855367](https://pubmed.ncbi.nlm.nih.gov/31855367/). *Unknown Journal*. [Epidemiology / Natural History]
Koundanya VV (2026). [PMID: 32644383](https://pubmed.ncbi.nlm.nih.gov/32644383/). *Unknown Journal*. [Epidemiology / Natural History]
Dutta Majumder P (2026). [PMID: 41632896](https://pubmed.ncbi.nlm.nih.gov/41632896/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Gurnani B (2026). [PMID: 28613659](https://pubmed.ncbi.nlm.nih.gov/28613659/). *Unknown Journal*. [Case Report / Case Series]
Olivas-Vergara OM (2025). [PMID: 40084348](https://pubmed.ncbi.nlm.nih.gov/40084348/). *Front Ophthalmol (Lausanne)*. [Clinical Trial Publication]
Zong Y (2025). [PMID: 40052203](https://pubmed.ncbi.nlm.nih.gov/40052203/). *J Med Virol*. [Epidemiology / Natural History]
Kotingová V (2025). [PMID: 39648037](https://pubmed.ncbi.nlm.nih.gov/39648037/). *Cesk Slov Oftalmol*. [Case Report / Case Series]
AI-curated news mentioning anterior uveitis
Updated Mar 10, 2026
A recent study published in PubMed examines the incidence of persistent anterior uveitis following cataract surgery in a diverse population in North West London. The findings contribute to understanding post-operative complications in this demographic.